Image For Activity Cover
Module 16: Management of Other Substance Use Disorders: Benzodiazepines, Cocaine and Other Stimulants, and Cannabis
Description
This educational activity reviews other substance use disorders that often co-occur with opioid use disorder (OUD), including benzodiazepines and other tranquilizers, cocaine and stimulants, and cannabis. The presentation will also discuss principles of diagnosis and evaluation of treatment for each of these by themselves and in the context of OUD.
Target Audience
Physicians, nurses, and healthcare teams who are treating patients with substance use disorder (SUD).
Presenter
Edward V. Nunes, MD | Columbia University Medical Center
Credit Designations Available
Interprofessional Continuing Education credit, AMA PRA Category 1 Credits™, and Nursing Contact Hours.
Core Competencies as a result of participating in this activity
Interpersonal Skills and Communication
Medical Knowledge
Patient Care
Educational Objectives
At the conclusion of this activity participants should be able to:

Diagnose and formulate a treatment plan for misuse and use disorders of the following substances:
Benzodiazepines,
Cocaine and other stimulants,
Cannabis
Method of participating in the learning process
In order to receive maximum credit, learners must:

1. Review the materials provided in this module.
2. Earn a minimum cumulative score of 80% on the post-test.
3. Complete an evaluation to assess satisfaction and plans for individual and/or team practice change.
4. Follow instructions at the end of the course regarding how to retrieve a certificate.*

*Credit will not be awarded unless all components of the program are completed. Partial credit will not be awarded.
Summary
Availability: On-Demand
Expires on 07/26/2022
Cost: FREE
Credit Offered:
1 CME Credit
1 Other Professionals Credit
1 Nursing Credit
1 IPCE Credit
Recommended
 
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.



Funding for this initiative was made possible (in part) by grant nos. 1H79TI081968 and 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

 
PCSS
pcssNow.org
pcss@aaap.org
For Waiver Inquiries, email PCSS.

ORN
opioidresponsenetwork.org

Powered By